No stimulation of in vitro cultivated tumor cells by mistletoe lectin;Keine stimulation in-vitro-kultivierter tumorzellen durch mistellektin

Deutsche Zeitschrift fur Onkologie

Volumn 36, Issue 2, 2004, Pages 66-70

  Büssing, Arndt ^a   Schietzel, D ^b   Schietzel, M ^b   Schink, M ^b   Stein, G M ^b  

^a UNIVERSITY OF WITTEN HERDECKE   (Germany)

^b NONE

Author keywords

Mistletoe lectins; Mistletoe therapy; Proliferation; Stimulation; Tumour cells; Viscum album

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; BROXURIDINE; CELL DNA; THYMIDINE DERIVATIVE; VISCUM ALBUM EXTRACT; VISCUM ALBUM LECTIN;

ARTICLE; CELL METABOLISM; CELL PROLIFERATION; CELL STIMULATION; DRUG MECHANISM; HUMAN; HUMAN CELL; IN VITRO STUDY; TUMOR CELL; TUMOR CELL CULTURE; VISCUM ALBUM;

EID: 3442880810     PISSN: 16175891     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-828263     Document Type: Article

References (9)

1. Berg PA, Stein GM: Does mistletoe therapy influence the defense against epithelial tumors? A critical immunologic analysis. Dtsch Med Wochenschr. 2001; 126: 339-345.
2. Büssing A (Hrsg.): Mistletoe. The Genus Viscum. Medicinal and Aromatic plants - Industrial Profiles. Amsterdam: Harwood Academic Publishers; 2002.
3. Büssing A: Pharmakologische Wirkungen von Mistelextrakten. In: V. Fintelmann (Hrsg.): Onkologie auf anthroposophischer Grundlage. Stuttgart: Johannes M. Mayer; 2002; Kapitel 3.2.4.1; 1-40.
4. Büssing A: Mistel (Viscum album) anthroposophischer und phytotherapeutischer Ansatz. In: K. Mfinstedt (Hrsg.): Ratgeber unkonventionelle Krebstherapien. Landsberg: Ecomed; 2003; 184-199.
5. Carayon P, Bord A: Identification of DNA-replicating lymphocyte subsets using a new method to label the bromo-deoxyuridine incorporated into the DNA. J Immunol Methods. 1992; 147: 225-230.
6. Gabius HJ, Darro F, Remmelink M, Andre S, Kopitz J, Danguy A, Gabius S, Salmon I, Kiss R: Evidence for stimulation of tumor proliferation in cell lines and histiotypic cultures by clinically relevant low doses of the galactoside-binding mistletoe lectin, a component of proprietary extracts. Cancer Invest. 2001; 19: 14-126.
7. Kienle GS, Kienle H: Die Mistel in der Onkologie. Fakten und konzeptionelle Grundlagen. Stuttgart: Schattauer; 2003.
8. Maier G, Fiebig HH: Absence of tumor growth stimulation in a panel of 16 human tumor cell lines by mistletoe extract in vitro. Anticancer Drugs. 2002; 13: 373-379.
9. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C: A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods. 1991; 139: 271-279.